Peter Mueller, Director at BioXcel Therapeutics, Inc. (BTAI), bought 1,554 shares at $9.34 ($15K) on 2019-08-23, disclosed to the SEC on 2019-08-26.
Open-market purchase of $15k BTAI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| BTAI | BUY | 2018-12-06 | $21K | — | Filing → |
| VRTX | SELL | 2014-06-18 | $512K | — | Filing → |
| VRTX | SELL | 2014-05-16 | $506K | — | Filing → |